Peptide encoded by lncRNA BVES-AS1 promotes cell viability, migration, and invasion in colorectal cancer cells via the SRC/mTOR signaling pathway
PLOS ONE · 22.06.2023 · 18 (6) · e0287133
DOI: 10.1371/journal.pone.0287133 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 22.06.2023. Verfasst von Weiwei Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, H…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Colorectal Neoplasms, MicroRNAs. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development and Promotion Project of Henan Province.
Abstract (Originalsprache)
Long non-coding RNAs (lncRNAs) have been revealed to harbor open reading frames (ORFs) that can be translated into small peptides. The peptides may participate in the pathogenesis of colorectal cancer (CRC). Herein, we investigated the role of a lncRNA BVES-AS1-encoded peptide in colorectal tumorigenesis. Through bioinformatic analysis, lncRNA BVES-AS1 was predicted to have encoding potential and to be associated with poor prognosis of patients with CRC. In CRC cells, BVES-AS1 was validated to encode a 50-aa-length micro-peptide, named BVES-AS1-201-50aa, through a western blotting method. BVES-AS1-201-50aa enhanced cell viability and promoted the migratory and invasive capacities of HCT116 and SW480 CRC cells in vitro , validated via CCK-8 assay and transwell assay, respectively. Immunofluorescence assay showed that BVES-AS1-201-50aa increased the expression of proliferating cell nuclear antigen (PCNA) and matrix metalloproteinase 9 (MMP9) in CRC cells. We further verified that BVES-AS1-201-50aa targeted and activated the Src/mTOR signaling pathway in CRC cells by co-immunoprecipitation (Co-IP) experiment, qualitative proteomic analysis, and western blotting. Our findings demonstrated that BVES-AS1 could encode a micro-peptide, which promoted CRC cell viability, migration, and invasion in vitro . Our current work broadens the diversity and breadth of lncRNAs in human carcinogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, Henan Province, China.
- Department of Interventional Therapy, the First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Henan Province, China.
- Department of General Surgery, Shangcai People's Hospital, Zhumadian, Henan Province, China.
ORCID-Profile: Chao Zhang
Förderung
- Key Research and Development and Promotion Project of Henan Province
Zitieren
APA
Zheng, W., Guo, Y., Zhang, G., Bai, J., Song, Y., Song, X., Zhu, Q., Bao, X., Wu, G., & Zhang, C. (2023). Peptide encoded by lncRNA BVES-AS1 promotes cell viability, migration, and invasion in colorectal cancer cells via the SRC/mTOR signaling pathway. PLOS ONE, 18(6), e0287133. https://doi.org/10.1371/journal.pone.0287133
Vancouver
Zheng W, Guo Y, Zhang G, Bai J, Song Y, Song X, et al. Peptide encoded by lncRNA BVES-AS1 promotes cell viability, migration, and invasion in colorectal cancer cells via the SRC/mTOR signaling pathway. PLOS ONE. 2023;18(6):e0287133. doi:10.1371/journal.pone.0287133
BibTeX
@article{Zheng2023,
author = {Zheng, Weiwei and Guo, Yingchang and Zhang, Guangtan and Bai, Junwei and Song, Yucheng and Song, Xiaofei and Zhu, Qinhui and Bao, Xuebin and Wu, Gang and Zhang, Chao},
title = {Peptide encoded by lncRNA BVES-AS1 promotes cell viability, migration, and invasion in colorectal cancer cells via the SRC/mTOR signaling pathway},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {6},
pages = {e0287133},
doi = {10.1371/journal.pone.0287133}
}
EUVIMED